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To define specific reactivities of PC-BL (WHO/EORTC 2008 classification), we 
analyzed, by using an  immunohistochemical method, the mAbs of the FACS panel 
of the 9th HLDA Workshop on tissue sections of the different cutaneous lymphomas 
entities: follicular centre B-cell lymphomas (FCL), marginal zone lymphomas (MZL) 
and diffuse large B-cells lymphomas (DLBL) leg-type. Cryostat sections of frozen 
tissues were dried for 12 hours, fixed 10" in aceton and stained by an avidin-biotin
immunoalkaline phosphatase method (DAKO). Tissue reactivities of lymphocytes 
and/or other resident cells were detected by using all mAbs, except for n° 49-51-81-
90-91-109. Specific lymphoma reactivities were detected on PC-BL: Group 1 mAbs 
stained all PC-BL: n° 88 (CD48). Group 2 mAbs stained PC-FCL: n°20(hFCRL1); 
34(CD152); 35 (CD80), 36(CD126); 37(PD1-CD279); 38(B7-DC-CD273); 40 
(CD200); 41(CD130); 46 (CD184-CXCR4); 47 (BTLA-CD272); 50(CD185-CXCR5);
56(CMKLR1); 57 (DR5); 77(Siglec-5/14); 83 (CRTAM); 86(CD229); 89 (CD84); 
93(NTBA); 94(HVEM); 96(TWEAK); 97(TCL1); 100(LT-betaR); 106(CD150). Group 3 
mAbs stained PC-MZL: n° 36(CD126); 47(BTLA); 50(CXCR5); 55(DR4); 77(Siglec-
5/14); 83(CRTAM); 84(DCIR/CLEC4A); 86(CD229); 87(CD319); 93(NTBA). Group 4 
mAbs stained PC-DLBL: n° 35(CD80); 36(CD126); 39(CD124); 50(CD185); 
55(DR4); 56(CMKLR1); 57(DR5); 75(Dectin-1); 76-101(TREM-1); 82(Integrin 
alfaVbeta5); 83(CRTAM); 85-99(GITR); 86(CD229); 87(CD319); 89(CD84); 92(Dr3-
TRAMP); 93(NTBA); 94(HVEM-CD258); 97(TCL-1); 100(Lymphotoxin betaR). 
Furthermore, variable mixed reactivities with infiltrating or neoplastic cells were 
observed by using several mAbs and other Mabs showed many tissue cross 
reactivities and were not easy to evaluate by IHC (further investigations may be done 
on "pure" infiltrates,  cell suspensions of neoplastic cells or by using double labeling 
techniques-confocal laser microscopy). Finally, mAbs n° 21-22-23-30-31-32-33-42-
44-45-48-49-51-52-53-54-58-74-78-79-80-81-82-84-90-91-98-109 were negative in 
all lymphoma cases. This study may be useful to better define specific profile of 
different PC-BL entities. 
